West Pharmaceutical Services Inc (WST)
377.45
-8.28
(-2.15%)
USD |
NYSE |
Apr 25, 10:06
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 27.63B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 3.98% |
Valuation | |
PE Ratio | 47.90 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 9.632 |
Price to Book Value | 9.591 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.20 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.0718 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 55.52% |
Profile
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States. |
URL | https://www.westpharma.com |
Investor Relations URL | https://www.westpharma.com/Investors |
HQ State/Province | Pennsylvania |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Mid Cap/Growth |
Next Earnings Release | Apr. 25, 2024 |
Last Earnings Release | Apr. 25, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 23, 2024 |
Ratings
Profile
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States. |
URL | https://www.westpharma.com |
Investor Relations URL | https://www.westpharma.com/Investors |
HQ State/Province | Pennsylvania |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Mid Cap/Growth |
Next Earnings Release | Apr. 25, 2024 |
Last Earnings Release | Apr. 25, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 23, 2024 |